Filana Therapeutics, Inc. (FLNA)

NASDAQ: FLNA · Real-Time Price · USD

1.010

+0.050 (5.21%)

At close: Jul 31, 2026, 4:00 PM EDT

1.003

-0.007 (-0.68%)

After-hours: Jul 31, 2026, 7:47 PM EDT

Filana Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	82.68	95.5	128.57	121.14	201.02	233.44
Cash & Short-Term Investments	82.68	95.5	128.57	121.14	201.02	233.44
Cash Growth	-26.43%	-25.72%	6.14%	-39.74%	-13.89%	149.65%
Other Current Assets	1.04	2.21	7.96	8.5	10.21	11.05
Total Current Assets	83.72	97.71	136.53	129.63	211.23	244.48
Net Property, Plant & Equipment	20.18	20.65	21	21.85	22.99	20.83
Other Intangible Assets	-	-	-	0.18	0.62	1.08
Other Long-Term Assets	-	-	-	-	-	0.4
Total Assets	103.9	118.36	157.53	151.66	234.83	266.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	39.29	41.65	7.65	10.57	4.02	7.13
Accrued Expenses	0.75	1.99	3.8	3.24	2.45	4.68
Current Portion of Leases	-	-	-	-	0.1	0.1
Other Current Liabilities	0.12	0.2	0.3	0.39	0.49	0.63
Total Current Liabilities	40.16	43.83	11.75	14.2	7.06	12.53
Long-Term Leases	-	-	-	-	0.04	0.14
Other Long-Term Liabilities	0.14	0.12	0.08	-	0.2	0.19
Total Long-Term Liabilities	0.14	0.12	0.08	-	0.23	0.33
Total Liabilities	40.29	43.95	11.83	14.2	7.3	12.87

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.04	0.04	0.04
Additional Paid-in Capital	578.58	570.44	550.77	518.2	511.05	461.18
Retained Earnings	-515.02	-496.08	-405.11	-380.77	-283.55	-207.31
Shareholders' Equity	63.61	74.4	145.7	137.47	227.54	253.92
Total Liabilities & Equity	103.9	118.36	157.53	151.66	234.83	266.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	0	0	0	0.14	0.24
Net Cash (Debt)	82.68	95.5	128.57	121.14	200.88	233.2
Net Cash Growth	-26.43%	-25.72%	6.14%	-39.70%	-13.86%	150.18%
Net Cash Per Share	1.71	1.98	2.76	2.89	5.00	5.92
Book Value	63.61	74.4	145.7	137.47	227.54	253.92
Book Value Per Share	1.32	1.54	3.13	3.28	5.66	6.44
Tangible Book Value	63.61	74.4	145.7	137.29	226.92	252.84
Tangible Book Value Per Share	1.32	1.54	3.13	3.27	5.64	6.42

SEC Filings: 10-K · 10-Q